Squarepoint’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17M | Buy |
163,000
+21,403
| +15% | +$2.23M | 0.02% | 438 |
|
|
2025
Q1 | $16.5M | Buy |
141,597
+52,167
| +58% | +$6.08M | 0.02% | 414 |
|
|
2024
Q4 | $7.57M | Buy |
+89,430
| New | +$7.57M | 0.01% | 616 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2545 |
|
|
2024
Q1 | – | Sell |
-2,550
| Closed | -$203K | – | 2440 |
|
|
2023
Q4 | $203K | Sell |
2,550
-94,211
| -97% | -$7.5M | ﹤0.01% | 2127 |
|
|
2023
Q3 | $6.76M | Buy |
+96,761
| New | +$6.76M | 0.02% | 503 |
|
|
2023
Q1 | – | Sell |
-44,616
| Closed | -$3.44M | – | 2268 |
|
|
2022
Q4 | $3.44M | Sell |
44,616
-87,977
| -66% | -$6.79M | 0.01% | 588 |
|
|
2022
Q3 | $5.92M | Buy |
132,593
+124,202
| +1,480% | +$5.54M | 0.03% | 405 |
|
|
2022
Q2 | $321K | Buy |
+8,391
| New | +$321K | ﹤0.01% | 1560 |
|
|
2021
Q4 | – | Sell |
-10,730
| Closed | -$354K | – | 2532 |
|
|
2021
Q3 | $354K | Sell |
10,730
-11,273
| -51% | -$372K | ﹤0.01% | 1555 |
|
|
2021
Q2 | $1.48M | Buy |
22,003
+9,474
| +76% | +$639K | 0.01% | 945 |
|
|
2021
Q1 | $709K | Buy |
+12,529
| New | +$709K | ﹤0.01% | 1301 |
|
|
2020
Q2 | – | Sell |
-18,234
| Closed | -$1.07M | – | 2150 |
|
|
2020
Q1 | $1.07M | Buy |
18,234
+7,937
| +77% | +$467K | 0.03% | 691 |
|
|
2019
Q4 | $1.06M | Buy |
+10,297
| New | +$1.06M | 0.01% | 1265 |
|
|
2019
Q3 | – | Sell |
-37,706
| Closed | -$971K | – | 2233 |
|
|
2019
Q2 | $971K | Buy |
+37,706
| New | +$971K | 0.01% | 1256 |
|
|
2018
Q1 | – | Sell |
-31,400
| Closed | -$176K | – | 1680 |
|
|
2017
Q4 | $176K | Sell |
31,400
-2,200
| -7% | -$12.3K | ﹤0.01% | 1821 |
|
|
2017
Q3 | $186K | Buy |
+33,600
| New | +$186K | ﹤0.01% | 1389 |
|